Rich Pharmaceuticals, Inc.: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $115.0K
- Net Income/Loss (FY2017)
- -$1.7M
- Total Assets (FY2017)
- $37.4K
- Total Equity (FY2017)
- -$6.4M
- Cash Flows from Operating Activities (FY2017)
- -$508.5K
Source: Rich Pharmaceuticals, Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
